Skip to main content

Table 2 Comparison between effective and non-effective cases

From: A study on prevention of bleeding complications using lusutrombopag for safe RFA in patients with hepatocellular carcinoma with low platelet counts: prospective observational study

 

Effective

Non-effective

p value

n

84

7

 

Sex Male(%)

53 (63)

5(71)

> 0.999

Age median(range)

71(51–86)

69(54–75)

0.702

Child Class A/ B + C

39/45

5/2

0.256

PLT pre (×104 PLT µL− 1)

4.5 ± 1.1

3.4 ± 1.4

0.012

Number of patietns PLT > 50,000

28 (33)

1 (14)

0.4236

Days to peak PLT value

12(5–18)

14(6–19)

0.191

Spleen index 30>

30     

20

64

2

5

0.674

  1. P < 0.05: statistically significant
  2. Categorical variables were described as number (percentage) and numerical variables as median (range). T-test for numerical variables and chi-square test or Fisher’s exact test for categorical variables